AfterROSC Next Meeting 02 February 2021

Published on by AfterROSC

We are pleased to announce our next meeting on 02 February 2021.

What’s on the menu ?

  • discussion about the research activities of the AfterROSC network
  • a journal club with an international expert in Cardiac Arrest
  • news about the last international Cardiac Arrest guidelines

Interesting discussions to come! Save the date!

Sessions “Arrêt Cardiaque” au congrès REANIMATION 2020

Published on by AfterROSC

Mercredi 5 Février 2020 11h00 – 12h20 Prise en charge hospitalière de l’arrêt cardiaque

Mercredi 5 / Jeudi 6 / Vendredi 7 Février 2020 10h00 – 12h00 puis 14h00 – 15h30 Centre de simulation 2 – Procédure de réanimation lors d’un ACR

Jeudi 6 Février 12h35 – 13h55 – Forum 6 – Contrôle thermique après arrêt cardiaque

Jeudi 6 Février 14h10 – 15h10 – Forum 1 – Toxicologie et arrêt cardiaque

Jeudi 6 Février 14h10 – 15h10 – E02 – Hémodynamique : arrêt cardiaque

Vendredi 7 Février 11h00 – 12h20 – Arrêt cardiaque extra-hospitalier

Jeudi 6 Février 14h10 – 15h10 – S02 – Arrêt cardiaque : la prise en charge initiale

HYPERION – Hot Topics Session – ESICM Lives 2019

Published on by AfterROSC

Don’t miss the Hot Topics Session – ESICM Lives 2019! Dr Jean-Baptiste LASCARROU (Nantes, FRANCE) will report study results live in BERLIN during the next ESICM congress (Lives 2019).

Hyperion was an open-label randomized controlled trial comparing moderate therapeutic hypothermia (33°C during the first 24 hours) to targeted normothermia (37°C) in comatose patients admitted to intensive care units after resuscitation from cardiac arrest with nonshockable rhythm. The primary outcome was survival with a favorable neurological outcome, assessed on post-randomization day 90 using the CPC scale.  A favorable neurological outcome was defined as CPC 1 or 2. Between January 2014 and January 2018, 584 patients were included and results will be release at ESICM 2019 during the hot topic session.